Sleep apnea is related to the atherogenic phenotype, lipoprotein subclass B

Journal of Clinical Sleep Medicine

Volumn 8, Issue 2, 2012, Pages 155-161

  Luyster, Faith S ^a   Kip, Kevin E ^b   Drumheller, Oliver J ^a   Rice, Thomas B ^a   Edmundowicz, Daniel ^a   Matthews, Karen ^c   Reis, Steven E ^a   Strollo, Patrick J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Atherosclerosis; Lipoproteins; Phenotype; Sleep apnea

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE TRIPHOSPHATE; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANXIOLYTIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CARDIOVASCULAR FUNCTION; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHENOTYPE; SLEEP APNEA SYNDROME; WAIST CIRCUMFERENCE;

EID: 84861152433     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.1768     Document Type: Article

References (40)

1. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. (Pubitemid 40386782)
2. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardio-vascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19-25. (Pubitemid 32095247)
3. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010;182:269-77.
4. Newman AB, Nieto FJ, Guidry U, et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 2001;154:50-9. (Pubitemid 32565686)
5. Roche F, Sforza E, Pichot V, et al. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 2009;10:882-6.
6. Rizzo M, Berneis K. Low-density lipoprotein size and cardiovascular risk assessment. QJM 2006;99:1-14. (Pubitemid 43124966)
7. Howard BV, Ruotolo G, Robbins DC. Obesity and dyslipidemia. Endocrinol Metab Clin North Am 2003;32:855-67. (Pubitemid 38029984)
8. Carr DB, Utzschneider KM, Hull RL, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004;53:2087-94. (Pubitemid 38970759)
9. Ross R, Rissanen J, Hudson R. Sensitivity associated with the identification of visceral adipose tissue levels using waist circumference in men and women: effects of weight loss. Int J Obes (Lond.) 1996;20:533-8. (Pubitemid 26174338)
10. Ainsworth BE, Jacobs DR Jr., Leon AS. Validity and reliability of self-reported physical activity status: the Lipid Research Clinics questionnaire. Med Sci Sports Exerc 1993;25:92-8. (Pubitemid 23027687)
11. Franklin BA, Whaley MH, Howley ET, eds. ACSM's guidelines for exercise testing and prescription. 6th ed. Philadelphia: Lippincott Williams and Wilkins, 2000.
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
13. Chung BH, Wilkinson T, Geer JC, Segrest JP. Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor. J Lipid Res 1980;21:284-91. (Pubitemid 10055505)
14. Kulkarni KR. Cholesterol profile measurement by vertical auto profile method. Clin Lab Med 2006;26:787-802. (Pubitemid 44724932)
15. Wang Y, Teschler T, Weinreich G, Hess S, Wessendorf TE, Teschler H. Validation of microMESAM as screening device for sleep disordered breathing. Pneumologie 2003;57:734-40. (Pubitemid 38102063)
16. Oktay B, Rice TB, Atwood CW, et al. Evaluation of a single channel portable monitor for the diagnosis of obstructive sleep apnea. J Clin Sleep Med 2011;7:384-390.
17. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 2004;25:735-41. (Pubitemid 38647933)
18. Kono M, Tatsumi K, Saibara T, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 2007;131:1387-92. (Pubitemid 46762343)
19. Tan KC, Chow WS, Lam JC, et al. HDL dysfunction in obstructive sleep apnea. Atherosclerosis 2006;184:377-82. (Pubitemid 43049723)
20. Kuller LH. Ethnic differences in atherosclerosis, cardiovascular disease and lipid metabolism. Curr Opin Lipidol 2004;15:109-13. (Pubitemid 38453398)
21. Bays HE, McGovern ME, Kopin L. Once daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin. Prev Cardiol 2003;6:179-188. (Pubitemid 37386151)
22. Yuan J, Tsaic MY, Hunninghake DB. Changes in composition and distribution of LDL subspecies in hypertriglyceridemic and hypercholesterolemic patients during gemfibrozil therapy. Atherosclerosis 1994;110:1-11. (Pubitemid 24312422)
23. Punjabi NM, Polotsky VY. Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005;99:1998-2007. (Pubitemid 41547203)
24. Drager LF, Jun J, Polotsky VY. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 2010;17:161-5.
25. Jun J, Reinke C, Bedja D, et al. Effect of intermittent hypoxia on atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis 2010;209:381-6.
26. Tkacova R, Rizzo M, Berneis K. Therapy with noninvasive ventilation in patients with obstructive sleep apnoea: effects on atherogenic lipoprotein phenotype. Med Hypotheses 2009;73:441-4.
27. Howard BV. Insulin resistance and lipid metabolism. Am J Cardiol 1999;84:28J-32J. (Pubitemid 29334858)
28. Li J, Thorne LN, Punjabi NM, et al. Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 2005;97:698-706. (Pubitemid 41416339)
29. Lattimore JD, Wilcox I, Nakhla S, Langenfeld M, Jessup W, Celermajer DS. Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis 2005;179:255-9. (Pubitemid 40364618)
30. Drager LF, Li J, Shin M, et al. Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea. Eur Heart J 2011; Apr 9 Epub ahead of print.
31. Hokanson JE, Brunzell JD, Jarvik GP, Wijsman EM, Austin MA. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet 1999;64:608-18. (Pubitemid 129500545)
32. Buckley TM, Schatzberg AF. On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 2005;90:3106-14. (Pubitemid 40686371)
33. Lanfranco F, Gianotti L, Pivetti S, et al. Obese patients with obstructive sleep apnoea syndrome show a peculiar alteration of the corticotroph but not of the thyrotroph and lactotroph function. Clin Endocrinol 2004;60:41-8. (Pubitemid 38183496)
34. Parlapiano C, Borgia MC, Minni A, Alessandri N, Basal I, Saponara M. Cortisol circadian rhythm and 24-hour Holter arterial pressure in OSAS patients. Endocr Res 2005;31:371-4. (Pubitemid 43207231)
35. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-62. (Pubitemid 38114528)
36. Quan SF, Gillin JC, Littner MR, Shepard JW. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
37. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39. (Pubitemid 34461732)
38. Young T, Shahar E, Nieto FJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002;162:893-900. (Pubitemid 34299121)
39. Erman M, Stewart D, Einhorn D, Gordon N, Casal E. Validation of the ApneaLink for the screening of sleep apnea: a novel and simple single-channel recording device. J Clin Sleep Med 2007;3:387-92. (Pubitemid 46984036)
40. Ayappa I, Norman RG, Suryadevara M, Rapoport DM. Comparison of limited monitoring using a nasal-cannula flow signal to full polysomnography in sleep-disordered breathing. Sleep 2004;27:1171-9. (Pubitemid 39331090)